Related Experiment Videos

Diagnosis and management of postoperative pulmonary hypertensive crisis

Circulation
|December 1, 1979
PubMed

Insights

A rare complication after ventricular septal defect repair involves pulmonary hypertensive crises. Tolazoline effectively treated two of three pediatric patients, improving right ventricular pressures and reducing hypoxia-induced vasoconstriction.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Critical Care Medicine

Background:

  • Complete correction of large, unrestrictive ventricular septal defects (VSD) is a standard procedure.
  • Uncommon complications can arise postoperatively, necessitating careful monitoring and management.
  • Pulmonary hypertensive crises and right-heart failure are severe potential adverse events.

Observation:

  • Three pediatric patients developed a previously unreported complication after VSD repair.
  • Two patients experienced pulmonary hypertensive crises and severe right-heart failure.
  • These crises were linked to hypoxia, pulmonary vasoconstriction, elevated right ventricular pressures, and right-to-left shunting through a patent foramen ovale.

Findings:

  • Tolazoline successfully treated the pulmonary hypertensive crises in two of the three patients.
  • In one patient, right ventricular pressures normalized post-tolazoline treatment and remained stable for 12 months.
  • While tolazoline reduced right ventricular pressures in the third patient, they did not normalize.

Implications:

  • Postoperative monitoring of pulmonary artery and right ventricular pressures is crucial for infants with large VSDs, especially when unexplained complications occur.
  • Tolazoline demonstrates efficacy in managing pulmonary vasoconstriction secondary to hypoxia in this context.
  • Early recognition and intervention are key to managing severe postoperative complications following VSD repair.

Related Concept Videos